2026 Rising Stars Application

BioNTX is proud to continue its tradition of recognizing the most promising emerging leaders in life sciences and healthcare innovation through the Rising Stars program, a key feature of the iC³ Life Science & Healthcare Innovation Summit. This program honors the next generation of leaders who have demonstrated significant achievements and are addressing some of the biggest challenges in these fields.

Who are the Rising Stars?

The Rising Stars are a select group of pioneering companies in Texas who have been meticulously chosen by the life sciences community for their outstanding potential to drive significant change through innovation and tenacity and to address the most pressing challenges we face in healthcare and life sciences.

Nomination Criteria

Emerging entrepreneurs
Innovative startups and early-stage companies
Researchers and scientists leading groundbreaking advancements
No more than $5 - $50 million revenue or direct investment

Thank you Davis/Yost Group at Morgan Stanley for being the Official Sponsor of the Rising Stars Program.

Fields marked with an * are required.

First Name *

Last Name *

Organization *

Provide a brief elevator pitch for your technology or solution. *

What category does your organization fall in *

Provide a summary of your technology or solution. *

Describe the problem you are solving, your solution, and why it is better than current alternatives.

How innovative is your solution? *

Describe the technical mechanism of action or other advantages over existing alternatives.

What is the market opportunity for your technology? *

Who are/would be the key competitors, and what is your clear value proposition and competitive edge?

What is your next major milestone, and what key risks do you foresee in achieving it? *

Describe any research, pre-clinical or clinical work that has been done to date. *

What is the potential to meaningfully improve patient outcomes or quality of life? *

Describe the regulatory, clinical, and/or reimbursement pathway for your technology or solution. *

Have any trademarks or patent protections been filed? *

How robust of an IP portfolio does the technology have now and in the future? Describe what is novel or non-obvious about your technology or solution and how it is differentiated from any prior art.

Describe your team’s scientific, clinical, regulatory and commercial expertise? *

Include relations with KOLs, key hires, advisors or partnerships.

What else could BioNTX do to help advance your technology/solution? *

Please verify that you have checked the “I'm not a robot” checkbox.